PubRank

Stan B Sidhu

Author PubWeight™ 77.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 20.08
2 Pheochromocytoma: current approaches and future directions. Oncologist 2008 2.05
3 Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 2010 1.73
4 miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer. Clin Cancer Res 2009 1.62
5 Potential pitfalls in the diagnosis of phaeochromocytoma. Med J Aust 2005 1.61
6 Surgeon performed ultrasound facilitates minimally invasive parathyroidectomy by the focused lateral mini-incision approach. World J Surg 2008 1.59
7 Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 2010 1.56
8 Minimally invasive thyroid surgery for single nodules: an evidence-based review of the lateral mini-incision technique. World J Surg 2008 1.53
9 Use of the Nerve Integrity Monitor during Thyroid Surgery Aids Identification of the External Branch of the Superior Laryngeal Nerve. Ann Surg Oncol 2014 1.46
10 Completion thyroidectomy for malignancy after initial minimal access thyroid surgery. ANZ J Surg 2006 1.37
11 BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 2010 1.36
12 Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy. ANZ J Surg 2007 1.24
13 MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 2011 1.22
14 Phaeochromocytoma: current concepts. Med J Aust 2005 1.18
15 1000 minimally invasive parathyroidectomies without intra-operative parathyroid hormone measurement: lessons learned. ANZ J Surg 2010 1.11
16 MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer 2010 1.11
17 Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist 2008 1.09
18 Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg 2010 1.07
19 MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer 2014 1.05
20 Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes. J Surg Oncol 2010 1.02
21 Standard and emerging therapies for metastatic differentiated thyroid cancer. Oncologist 2010 1.00
22 Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007 0.97
23 Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 2007 0.96
24 Parathyroid autotransplantation during total thyroidectomy--does the number of glands transplanted affect outcome? World J Surg 2005 0.95
25 Takotsubo cardiomyopathy complicating thyroidectomy for Graves' disease. Thyroid 2012 0.93
26 Dysregulation of microRNAs in adrenocortical tumors. Mol Cell Endocrinol 2011 0.92
27 Current and emerging therapies for advanced adrenocortical carcinoma. Oncologist 2011 0.92
28 Nerve stimulation in thyroid surgery: is it really useful? ANZ J Surg 2007 0.92
29 The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Ann Surg Oncol 2009 0.91
30 Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Ann Surg 2008 0.91
31 Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 2009 0.90
32 Current management options for recurrent adrenocortical carcinoma. Onco Targets Ther 2013 0.89
33 Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ J Surg 2010 0.88
34 Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol 2013 0.88
35 Outcomes of surgically managed pediatric thyroid cancer. J Surg Res 2009 0.88
36 Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. Cancer Med 2014 0.87
37 Two hundred consecutive parathyroid ultrasound studies by a single clinician: the impact of experience. Endocr Pract 2006 0.86
38 Use of the ligaSure vessel sealing system in laparoscopic adrenalectomy. ANZ J Surg 2006 0.86
39 The Delphian lymph node in thyroid cancer. Ann Surg 2008 0.86
40 Improving Outcomes in Adrenocortical Cancer: An Australian Perspective. Ann Surg Oncol 2014 0.85
41 Patterns of structural recurrence in papillary thyroid cancer. World J Surg 2014 0.84
42 Sutureless thyroidectomy: surgical technique. ANZ J Surg 2012 0.83
43 Diagnostic utility of fine-needle aspiration cytology in pediatric differentiated thyroid cancer. World J Surg 2010 0.83
44 Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases. ANZ J Surg 2013 0.83
45 Safety and feasibility of thyroid lobectomy via a lateral 2.5-cm incision with a cohort comparison of the first 50 cases: evolution of a surgical approach. Langenbecks Arch Surg 2005 0.81
46 Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery 2013 0.80
47 Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma. J Surg Res 2008 0.80
48 Evolution of the "autophagamiR". Autophagy 2011 0.79
49 New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ J Surg 2006 0.78
50 Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ J Surg 2012 0.78
51 Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ J Surg 2009 0.77
52 Minimally invasive parathyroidectomy using the lateral focused miniincision approach: Is there a learning curve for surgeons experienced in the open procedure? J Am Coll Surg 2007 0.77
53 A randomized controlled trial of minimally invasive thyroidectomy using the lateral direct approach versus conventional hemithyroidectomy. Surgery 2008 0.77
54 Oncophagy: harnessing regulation of autophagy in cancer therapy. Endocr Relat Cancer 2012 0.77
55 Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism. ANZ J Surg 2013 0.76
56 Noncoding RNAs in endocrine malignancy. Oncologist 2014 0.76
57 Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell 2016 0.76
58 Thermal sealing systems with and without tissue divider for total thyroidectomy. ANZ J Surg 2013 0.75
59 Adrenocortical carcinoma. Cancer Treat Res 2010 0.75
60 Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery. World J Surg 2011 0.75
61 Re: Avoiding recurrent laryngeal nerve injury in thyroid surgery. ANZ J Surg 2014 0.75
62 Re: minimally invasive parathyroidectomy: an audit of change in clinical practice. ANZ J Surg 2007 0.75
63 New surgical consultants: is there a learning curve? ANZ J Surg 2006 0.75
64 Simultaneous branchial cleft and thyroid disorders may present a management challenge. ANZ J Surg 2005 0.75
65 Pheochromocytoma and paraganglioma. Cancer Treat Res 2010 0.75
66 [Recurrent neck abscess due to a branchial cleft remnant]. Ned Tijdschr Geneeskd 2013 0.75
67 A case of sibling rivalry? J Am Coll Surg 2006 0.75
68 Durability of focused minimally invasive parathyroidectomy in young patients with sporadic primary hyperparathyroidism. Ann Surg Oncol 2010 0.75
69 Reoperative adrenal surgery: lessons learnt. ANZ J Surg 2009 0.75
70 Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation. Endocr Pathol 2015 0.75